Clinical trial
Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in…
NCT00017680 · Herbert Irving Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00017680 |
|---|---|
| Title | Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis |
| Official title | Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in |
| Lead sponsor | Herbert Irving Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Amyloidosis |
| Intervention type | Drug, Procedure |
| Interventions | Melphalan, Autologous Stem Cell Transplantation |
| Enrollment | 25 |
| Start date | Jul 1, 1999 |
| Primary completion | Apr 1, 2004 |
| Completion | Apr 1, 2004 |
| First posted | Jun 6, 2001 |
| Last update posted | Jun 9, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: